8-K: Tilray Brands Reports Q3 Fiscal 2025 Financial Results; Confirms No Current Impact of Tariffs

Tilray Brands reports net revenue of $186 million in Q3 2025, with strategic initiatives impacting revenue by $13 million, while also reducing debt and expanding U.S. distribution of hemp-derived THC drinks.

Summary

• Tilray Brands reported its Q3 fiscal year 2025 financial results, with net revenue reaching $186 million, or $193 million on a constant currency basis.
• Strategic initiatives and SKU rationalization negatively impacted revenue by $13 million.
• The company's beverage alcohol net revenue increased to $55.9 million, despite a $6 million impact from SKU rationalization.
• Cannabis net revenue was $54.3 million, but would have been $57.5 million on a constant currency basis.
• Tilray's Cannabis segment saw gross margins increase by 800 bps.
• The company reduced its outstanding total debt by $71 million, including a $58 million convertible note reduction.
• Tilray has $248 million available in cash and marketable securities.
• The company is revising its fiscal year 2025 net revenue guidance to $850 million to $900 million.
• Net loss was $(793.5) million in the third quarter, due to ~$700 million of non-cash impairment as a result of macroeconomic conditions and declines in market capitalization, foreign exchange loss, amortization, changes in fair value of convertible notes receivable, and stock-based compensation as well as non-recurring transaction and restructuring charges.

Sentiment

Score: 5

Explanation: The report contains both positive elements like debt reduction and gross margin improvements, but is weighed down by a significant net loss and revised revenue guidance. The sentiment is neutral.

Positives

• Tilray Beverage expands U.S. distribution of hemp-derived THC drinks across 10 states.
• Tilray Cannabis increased gross margins by 800 bps.
• The company reduced its outstanding total debt by $71 million.
• Tilray has $248 million available in cash and marketable securities.
• Tilray Beverage completed $20.6 million of an expanded Project 420 cost-savings plan of $33 million.
• Wellness net revenue increased 5% to $14.1 million and 8% on a constant currency basis to $14.5 million in the third quarter compared to $13.4 million in the prior year quarter.
• Wellness gross margin increased to 32% in the third quarter compared to 30% in the prior year quarter.

Negatives

• Strategic initiatives and SKU rationalization impacted revenue by $13 million.
• Cannabis net revenue was $54.3 million, down from $63.4 million in the prior year quarter.
• Adjusted EBITDA in the third quarter was $9.0 million compared to $10.2 million in the prior year quarter.
• Net loss was $(793.5) million in the third quarter, due to ~$700 million of non-cash impairment as a result of macroeconomic conditions and declines in market capitalization, foreign exchange loss, amortization, changes in fair value of convertible notes receivable, and stock-based compensation as well as non-recurring transaction and restructuring charges.

Risks

• The company is revising its fiscal year 2025 net revenue guidance to $850 million to $900 million.
• Macroeconomic conditions and market capitalization declines led to a significant non-cash impairment charge.
• The strategic decision to pause presence in margin dilutive categories, such as vapes and infused pre-rolls, led to a revenue decrease of $4.0 million.

Future Outlook

The Company revises fiscal year 2025 guidance for net revenue to $850 million to $900 million.

Management Comments

• Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, stated, 'Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning the beverage, cannabis, and wellness industries.'
• Mr. Simon continued, 'We see opportunities in the alcohol, cannabis, and wellness industries and believe these sectors are here to stay.'

Industry Context

Tilray is positioning itself as a global lifestyle and consumer packaged goods company, focusing on the beverage, cannabis, and wellness industries, and is expanding its presence in the U.S. hemp-derived THC beverage market.

Comparison to Industry Standards

• Tilray's strategy of expanding into hemp-derived THC beverages mirrors moves by other cannabis companies seeking to capitalize on the evolving regulatory landscape in the U.S.
• The company's focus on cost savings through Project 420 is a common strategy in the cannabis industry, as companies strive for profitability in a competitive market.
• Tilray's debt reduction efforts align with industry trends, as companies seek to strengthen their balance sheets and improve financial flexibility.

Stakeholder Impact

• Shareholders may be concerned about the net loss and revised revenue guidance.
• Employees may be affected by the Project 420 cost-savings plan.
• Customers may benefit from the expansion of hemp-derived THC beverage offerings.

Next Steps

• Complete Project 420 cost-savings plan by Q3 fiscal 2026.
• Continue expanding the global cannabis supply chain.
• Further implement AI across global operations.
• Explore strategic initiatives related to cryptocurrency.

Key Dates

Keywords

Tilray Brands, financial results, cannabis, beverage, wellness, revenue, debt reduction, THC drinks, gross margin, Project 420, AI, cryptocurrency